Baidu
map

消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2018 ASGE指南：Barrett''s食管相关性发育不良以及粘膜内癌患者内镜下根除治疗

2018-04-01 美国胃肠内镜学会 Gastrointest Endosc. 2018 Apr;87(4):907-931.

Barrett's食管发育不良粘膜内癌内镜下根除治疗

2018年4月，美国胃肠内镜学会(ASGE)发布了Barrett's食管相关性发育不良以及粘膜内癌患者内镜下根除治疗指南。主要目的是针对内镜根除治疗Barrett's食管相关性肿瘤形成的关键问题提出循证指导建议和临床指南。全文共针对7个临床问题提出指导建议。

中文标题：

2018 ASGE指南：Barrett''s食管相关性发育不良以及粘膜内癌患者内镜下根除治疗

英文标题：

Endoscopic eradication therapy for patients with Barrett''s esophagus-associated dysplasia and intramucosal cancer.

发布机构：

美国胃肠内镜学会

发布日期：

2018-04-01

简要介绍：

2018年4月，美国胃肠内镜学会(ASGE)发布了Barrett's食管相关性发育不良以及粘膜内癌患者内镜下根除治疗指南。主要目的是针对内镜根除治疗Barrett's食管相关性肿瘤形成的关键问题提出循证指导建议和临床指南。全文共针对7个临床问题提出指导建议。

 

拓展指南：与食管相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ASGE指南：Barrett''s食管相关性发育不良以及粘膜内癌患者内镜下根除治疗)] GetToolGuiderByIdResponse(projectId=1, id=f49cc1c00158023c, title=2018 ASGE指南：Barrett''s食管相关性发育不良以及粘膜内癌患者内镜下根除治疗, enTitle=Endoscopic eradication therapy for patients with Barrett''s esophagus-associated dysplasia and intramucosal cancer., guiderFrom=Gastrointest Endosc. 2018 Apr;87(4):907-931., authorId=null, author=, summary=2018年4月，美国胃肠内镜学会(ASGE)发布了Barrett's食管相关性发育不良以及粘膜内癌患者内镜下根除治疗指南。主要目的是针对内镜根除治疗Barrett's食管相关性肿瘤形成的关键问题提出循证指导建议和临床指南。全文共针对7个临床问题提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=366, associationName=美国胃肠内镜学会, associationIntro=Since its founding in 1941, the American Society for Gastrointestinal Endoscopy (ASGE) has been dedicated to advancing patient care and digestive health by promoting excellence and innovation in gastrointestinal endoscopy. ASGE, with nearly 12,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endoscopy, and is the foremost resource for endoscopic education., copyright=0, guiderPublishedTime=Sun Apr 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年4月，美国胃肠内镜学会(ASGE)发布了Barrett's食管相关性发育不良以及粘膜内癌患者内镜下根除治疗指南。主要目的是针对内镜根除治疗Barrett's食管相关性肿瘤形成的关键问题提出循证指导建议和临床指南。全文共针对7个临床问题提出指导建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>食管</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=ae0b51c0015e2adf" title="2018 NASPGHAN/ESPGHAN临床实践指南：儿童胃食管反流" target=_blank>2018 NASPGHAN/ESPGHAN临床实践指南：儿童胃食管反流</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=df1f81c0015e223d" title="NCCN临床实践指南：食道癌和胃食管交界处癌（2018.V1）" target=_blank>NCCN临床实践指南：食道癌和胃食管交界处癌（2018.V1）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=48bc51c0015618b8" title="2018 UK指南：食管扩张" target=_blank>2018 UK指南：食管扩张</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=ee4361c0015530d0" title="经食管超声心动图临床应用中国专家共识" target=_blank>经食管超声心动图临床应用中国专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=2c8aa1c0015235e6" title="食管癌根治术胸部淋巴结清扫中国专家共识（2017版）" target=_blank>食管癌根治术胸部淋巴结清扫中国专家共识（2017版）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E9%A3%9F%E7%AE%A1" target=_blank>有关食管更多指南</a></ul>, tagList=[TagDto(tagId=56088, tagName=Barrett's食管), TagDto(tagId=7731, tagName=发育不良), TagDto(tagId=73407, tagName=粘膜内癌), TagDto(tagId=73408, tagName=内镜下根除治疗)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4156, appHits=90, showAppHits=0, pcHits=2922, showPcHits=1519, likes=134, shares=4, comments=6, approvalStatus=1, publishedTime=Mon Apr 16 22:19:53 CST 2018, publishedTimeString=2018-04-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Apr 16 22:19:53 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 14:07:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ASGE指南：Barrett''s食管相关性发育不良以及粘膜内癌患者内镜下根除治疗)])
2018 ASGE指南：Barrett''s食管相关性发育不良以及粘膜内癌患者内镜下根除治疗
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=812420, encodeId=2ac4812420f4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91321931483, createdName=1e0ce281m58(暂无匿称), createdTime=Sun Aug 23 14:09:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308052, encodeId=7c1d308052a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Sun Apr 22 00:34:01 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306787, encodeId=e27f306e8703, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Wed Apr 18 05:33:03 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306482, encodeId=d6a530648263, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue Apr 17 04:58:40 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306437, encodeId=222a30643ebb, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Apr 16 23:24:30 CST 2018, time=2018-04-16, status=1, ipAttribution=)]
    2020-08-23 1e0ce281m58(暂无匿称)

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=812420, encodeId=2ac4812420f4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91321931483, createdName=1e0ce281m58(暂无匿称), createdTime=Sun Aug 23 14:09:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308052, encodeId=7c1d308052a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Sun Apr 22 00:34:01 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306787, encodeId=e27f306e8703, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Wed Apr 18 05:33:03 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306482, encodeId=d6a530648263, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue Apr 17 04:58:40 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306437, encodeId=222a30643ebb, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Apr 16 23:24:30 CST 2018, time=2018-04-16, status=1, ipAttribution=)]
    2018-04-22 121832a9m88暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=812420, encodeId=2ac4812420f4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91321931483, createdName=1e0ce281m58(暂无匿称), createdTime=Sun Aug 23 14:09:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308052, encodeId=7c1d308052a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Sun Apr 22 00:34:01 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306787, encodeId=e27f306e8703, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Wed Apr 18 05:33:03 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306482, encodeId=d6a530648263, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue Apr 17 04:58:40 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306437, encodeId=222a30643ebb, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Apr 16 23:24:30 CST 2018, time=2018-04-16, status=1, ipAttribution=)]
    2018-04-18 121832a9m88暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=812420, encodeId=2ac4812420f4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91321931483, createdName=1e0ce281m58(暂无匿称), createdTime=Sun Aug 23 14:09:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308052, encodeId=7c1d308052a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Sun Apr 22 00:34:01 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306787, encodeId=e27f306e8703, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Wed Apr 18 05:33:03 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306482, encodeId=d6a530648263, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue Apr 17 04:58:40 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306437, encodeId=222a30643ebb, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Apr 16 23:24:30 CST 2018, time=2018-04-16, status=1, ipAttribution=)]
    2018-04-17 秀红

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=812420, encodeId=2ac4812420f4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91321931483, createdName=1e0ce281m58(暂无匿称), createdTime=Sun Aug 23 14:09:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308052, encodeId=7c1d308052a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Sun Apr 22 00:34:01 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306787, encodeId=e27f306e8703, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Wed Apr 18 05:33:03 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306482, encodeId=d6a530648263, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue Apr 17 04:58:40 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306437, encodeId=222a30643ebb, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Apr 16 23:24:30 CST 2018, time=2018-04-16, status=1, ipAttribution=)]
    2018-04-16 1ddf0692m34(暂无匿称)

    学习了.谢谢分享

    0

相关指南

2017 ESGE立场声明：Barrett’s食管内镜管理

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2017-02-01

Baidu
map
Baidu
map
Baidu
map